8-KFiled Aug 11, 8:00 PM ET

Journey Medical Corp Reports Results for Quarter Ended June 30, 2026

$DERM · Journey Medical Corp

Research Summary

AI-generated summary of this SEC filing

Updated

Journey Medical Corp Reports Results for Quarter Ended June 30, 2026

What Happened
Journey Medical Corporation announced and furnished a press release on August 12, 2026 providing a corporate update and its financial results for the three months ended June 30, 2026. The press release is furnished as Exhibit 99.1 to the Form 8-K; the company states this information is being furnished (not “filed”) under the Exchange Act and is not automatically subject to Section 18 liability or incorporation by reference into other filings.

Key Details

  • Date of announcement: August 12, 2026.
  • Reporting period: three months ended June 30, 2026 (quarterly results/earnings information provided in the press release).
  • Exhibit furnished: Exhibit 99.1 (press release); cover page iXBRL data furnished as Exhibit 104.
  • Disclosure status: Information is furnished (not filed) and thus not subject to Section 18 liability or routine incorporation by reference.

Why It Matters
Quarterly results and corporate updates are primary inputs investors use to evaluate revenue, earnings, cash flow, and near-term outlook. Because the detailed numbers and commentary are in the furnished press release, investors should review Exhibit 99.1 for revenue, net income/loss, guidance, and any operational updates. Note the company’s legal statement that the release is furnished—not filed—which affects how the information may be used in later SEC filings.